Literature DB >> 10967434

The degradation pathways of glucagon in acidic solutions.

A B Joshi1, E Rus, L E Kirsch.   

Abstract

OBJECTIVE: Glucagon is a 29 amino acid peptide hormone that exhibits degradation via both chemical and physical pathways. The objective of the studies reported herein was to identify the degradation products and scheme for glucagon hydrolysis in acidic solutions.
METHODS: Solutions of glucagon in 0.01 N HCl (pH 2.5) were degraded at 60 degrees C for 70 h. One isocratic and two gradient RP-HPLC methods were developed to separate the degradation products. Structure elucidation of the separated peaks was achieved using amino acid sequencing, amino acid analysis, and mass spectrometry. Degradation was carried out in the pH range 1.5-5 to check for changes in degradation scheme with pH. Authentic samples of degradation products were degraded under similar acidic conditions to confirm precursor successor relationships in the degradation scheme.
RESULTS: Sixteen major degradation products were isolated and identified. The major pathways of degradation were found to be aspartic acid cleavage at positions 9, 15, and 21 and glutaminyl deamidation at positions 3, 20, and 24. Cleavage occurred on both sides of Asp-15 but only on the C-terminal side of Asp-9 and Asp-21. Deamidation of the Asn residue at position 28 was not detected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967434     DOI: 10.1016/s0378-5173(00)00438-5

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  17 in total

1.  Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations.

Authors:  Wei-Jie Fang; Wei Qi; John Kinzell; Steven Prestrelski; John F Carpenter
Journal:  Pharm Res       Date:  2012-07-06       Impact factor: 4.200

2.  Optimization of the native glucagon sequence for medicinal purposes.

Authors:  Joseph R Chabenne; Maria A DiMarchi; Vasily M Gelfanov; Richard D DiMarchi
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

3.  A density functional theory study on peptide bond cleavage at aspartic residues: direct vs cyclic intermediate hydrolysis.

Authors:  Wichien Sang-aroon; Vittaya Amornkitbamrung; Vithaya Ruangpornvisuti
Journal:  J Mol Model       Date:  2013-11-17       Impact factor: 1.810

4.  Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions.

Authors:  Hong-Jian Zheng; Bin-Bin Shen; Jing Wang; Haibin Wang; Guo-Li Huo; Li-Rui Huang; Jian-Qing Gao; Wei-Jie Fang
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

5.  Mechanisms of glucagon degradation at alkaline pH.

Authors:  Nicholas Caputo; Jessica R Castle; Colin P Bergstrom; Julie M Carroll; Parkash A Bakhtiani; Melanie A Jackson; Charles T Roberts; Larry L David; W Kenneth Ward
Journal:  Peptides       Date:  2013-05-04       Impact factor: 3.750

6.  A novel, stable, aqueous glucagon formulation using ferulic acid as an excipient.

Authors:  Parkash A Bakhtiani; Nicholas Caputo; Jessica R Castle; Joseph El Youssef; Julie M Carroll; Larry L David; Charles T Roberts; W Kenneth Ward
Journal:  J Diabetes Sci Technol       Date:  2014-09-24

7.  Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use.

Authors:  Nadine Taleb; Adèle Coriati; Christian Khazzaka; Jonathan Bayonne; Virginie Messier; Rémi Rabasa-Lhoret
Journal:  Diabetes Technol Ther       Date:  2017-08-28       Impact factor: 6.118

Review 8.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

9.  Stabilized glucagon formulation for bihormonal pump use.

Authors:  Solomon S Steiner; Ming Li; Robert Hauser; Roderike Pohl
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

10.  Hormone glucagon: electrooxidation and determination at carbon nanotubes.

Authors:  Sushma Karra; Wendell P Griffith; Robert T Kennedy; Waldemar Gorski
Journal:  Analyst       Date:  2016-03-03       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.